Next Article in Journal
New Stability Indicating RP-HPLC Method for the Estimation of Cefpirome Sulphate in Bulk and Pharmaceutical Dosage Forms
Previous Article in Journal
A Standard Protocol for the Calibration of Capillary Electrophoresis (CE) Equipment
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 79
Issue 4
10.3797/scipharm.1108-07
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

High-Throughput NIR-Chemometric Method for Meloxicam Assay from Powder Blends for Tableting

by
Ioan TOMUTA
1,*,
Rares IOVANOV
1,
Andreea Loredana VONICA
2 and
Sorin E. LEUCUTA
1
1
Department of Pharmaceutical Technology and Biopharmaceutics, “Iuliu Hatieganu” University of Medicine and Pharmacy, 41 V. Babes Street, 400023, Cluj-Napoca, Romania
2
S. C. Polipharma Industries, 550052, Sibiu, Romania
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2011, 79(4), 885-898; https://doi.org/10.3797/scipharm.1108-07
Submission received: 10 August 2011 / Accepted: 13 October 2011 / Published: 13 October 2011
Versions Notes

Abstract

A near infrared (NIR) method able to directly quantify the active content in pharmaceutical powder blends used for manufacturing meloxicam tablets, without any sample preparation, was developed and fully validated. To develop calibration models for the assay of meloxicam in powder blends for tableting, the NIR reflectance spectra of different meloxicam powder blends prepared according to a calibration protocol was analysed using different pre-processing methods by partial last-square regression (PLS) and principal component regression (PCR). The best calibration model was found when partial last-square regression (PLS) was used as regression algorithm in association with Smoothing-Savitsky as pre-processing spectrum method. The trueness, precision (repeatability and intermediate precision), accuracy, linearity and range of application of the developed NIR method were validated according to the International Conference of Harmonization (ICH) and Medicine European Agency (EMA) guidelines and found to be fit for its intended purpose.
Keywords: Near Infrared Spectroscopy; Chemometrics; Meloxicam assay; Powder blends; Method validation Near Infrared Spectroscopy; Chemometrics; Meloxicam assay; Powder blends; Method validation

Share and Cite

MDPI and ACS Style

TOMUTA, I.; IOVANOV, R.; VONICA, A.L.; LEUCUTA, S.E. High-Throughput NIR-Chemometric Method for Meloxicam Assay from Powder Blends for Tableting. Sci. Pharm. 2011, 79, 885-898. https://doi.org/10.3797/scipharm.1108-07

AMA Style

TOMUTA I, IOVANOV R, VONICA AL, LEUCUTA SE. High-Throughput NIR-Chemometric Method for Meloxicam Assay from Powder Blends for Tableting. Scientia Pharmaceutica. 2011; 79(4):885-898. https://doi.org/10.3797/scipharm.1108-07

Chicago/Turabian Style

TOMUTA, Ioan, Rares IOVANOV, Andreea Loredana VONICA, and Sorin E. LEUCUTA. 2011. "High-Throughput NIR-Chemometric Method for Meloxicam Assay from Powder Blends for Tableting" Scientia Pharmaceutica 79, no. 4: 885-898. https://doi.org/10.3797/scipharm.1108-07

APA Style

TOMUTA, I., IOVANOV, R., VONICA, A. L., & LEUCUTA, S. E. (2011). High-Throughput NIR-Chemometric Method for Meloxicam Assay from Powder Blends for Tableting. Scientia Pharmaceutica, 79(4), 885-898. https://doi.org/10.3797/scipharm.1108-07

Article Metrics

Back to TopTop